Skip to main content
Explore URMC

menu

Acute Myeloid Leukemia (AML): Uproleselan Administered With Chemotherapy Versus Chemotherapy Alone in Patients With Relapsed/Refractory AML

Research Question:
Does the drug Uproleselan help the survival of patients with acute myeloid leukemia?

Basic Study Information

Purpose:
The purpose of this trial is to compare overall survival achieved with uproleselan administered with chemotherapy versus chemotherapy alone.

Study Reference #: ILEU18074

Lead Researcher (Principal Investigator)

Lead Researcher: Jane Liesveld, MD

Study Contact Information

Study Coordinator: Haley Misch
Phone: (585) 275-9485

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search